JAMA Oncology

JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Publisher
JAMA

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Health disparity for blacks exists within lung screening guidelines

The U.S. Preventive Services Task Force (USPSTF) guidelines that determine which smokers qualify for CT scans exclude significant numbers of African Americans who develop lung cancer, a health disparity that merits modifications ...

Oncology & Cancer

Nearly 5.4 million cancer survivors suffer chronic pain

A new report finds about one in three cancer survivors (34.6%) reported having chronic pain, representing nearly 5.4 million cancer survivors in the United States. The report, appearing as a Research Letter in JAMA Oncology, ...

Oncology & Cancer

Black race not tied to worse prostate cancer mortality

(HealthDay)—After adjustment for nonbiological differences, black race is not associated with worse prostate cancer-specific mortality among men with nonmetastatic prostate cancer, according to a study published online ...

Medical research

Mouth rinse for HPV DNA may be biomarker in head, neck cancer

(HealthDay)—Human papillomavirus (HPV) DNA detected from a mouth rinse may be an effective marker for prognosis during treatment of HPV-positive head and neck cancer, according to a study recently published in JAMA Oncology.

page 1 from 33